SRTA — Strata Critical Medical Balance Sheet
0.000.00%
- $424.80m
- $311.38m
- $248.69m
- 77
- 54
- 56
- 68
Annual balance sheet for Strata Critical Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 12.2 | 282 | 194 | 166 | 127 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.09 | 5.55 | 10.9 | 21 | 21.6 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 14.4 | 295 | 218 | 206 | 161 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.5 | 2.76 | 19.7 | 26.4 | 39.8 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 17.7 | 336 | 325 | 295 | 257 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.34 | 12.8 | 26.6 | 35.5 | 22.7 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.63 | 44.5 | 50.5 | 60.6 | 34.7 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 11.1 | 291 | 274 | 234 | 222 |
| Total Liabilities & Shareholders' Equity | 17.7 | 336 | 325 | 295 | 257 |
| Total Common Shares Outstanding |